Christopher Belham

Q: What is Christopher Belham email address?

Email Christopher Belham at christopher.belham@roche.com. This email is the most updated Christopher Belham email found in 2026.

Q: How to contact Christopher Belham?

To contact Christopher Belham send an email to christopher.belham@roche.com.

Senior Principal Regulatory Documentation Scientist (Medical Writer) at F. Hoffmann-La Roche AG | Basel, Basel, Switzerland

About Christopher Belham

Christopher Belham is a seasoned Senior Principal Regulatory Documentation Scientist at F. Hoffmann-La Roche AG, where he leverages over 30 years of extensive scientific knowledge and experience in both academia and the pharmaceutical industry. In his current role, Christopher leads the strategic planning, resourcing, and preparation of clinical and safety documentation, ensuring compliance with global regulatory standards for a diverse portfolio of products. His expertise spans across various stages of drug development, from early-stage research to late-stage clinical trials, making him a pivotal figure in the successful navigation of complex regulatory landscapes.

Christopher's proficiency in molecular biology, drug discovery, and clinical development is complemented by his ability to distill intricate data from large datasets into actionable insights. His analytical skills enable him to derive key scientific conclusions that inform critical decision-making processes. As a consultant, mentor, and trainer, he is dedicated to enhancing the medical writing capabilities of his colleagues, fostering a culture of excellence and continuous improvement within the organization. Additionally, his certification as a Life Coach underscores his commitment to personal and professional development, equipping him to guide others in achieving their goals.

Among his key projects, Christopher has contributed significantly to the preparation of regulatory submissions that have successfully advanced multiple therapeutic candidates through the pipeline. His collaborative approach and strong communication skills ensure that complex scientific findings are articulated clearly, facilitating effective dialogue with regulatory authorities and stakeholders alike. With a robust foundation in biochemistry, protein chemistry, and biomarker validation, Christopher Belham exemplifies the intersection of scientific rigor and regulatory acumen, making him an invaluable asset to F. Hoffmann-La Roche AG and the broader pharmaceutical community.

Christopher Belham Work